The emerging threat of fluroquinolone-, bedaquiline-, and linezolid-resistant Mycobacterium tuberculosis in China: Observations on surveillance data

• Main Authors: Shanshan Li (Author), Yaoju Tan (Author), Yufeng Deng (Author), Guanghong Bai (Author), Mingxiang Huang (Author), Yuanyuan Shang (Author), Yufeng Wang (Author), Zhongtan Xue (Author), Xuxia Zhang (Author), Wei Wang (Author), Junhua Pan (Author), Yu Pang (Author)
• Format: Book
• Published: Elsevier, 2024-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Drug-resistant tuberculosis (TB), especially multidrug-resistant tuberculosis (MDR-TB), constitutes a major obstacle to fulfill end TB strategy globally. Although fluoroquinolones (FQs), linezolid (LZD) and bedaquiline (BDQ) were classified as Group A drugs for MDR-TB treatment, our know...